Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Research output: Contribution to journalJournal articleResearchpeer-review

  • Elsayed Z Soliman
  • Lundgren, Jens
  • Mollie P Roediger
  • Daniel A Duprez
  • Zelalem Temesgen
  • Markus Bickel
  • Judith C Shlay
  • Charurut Somboonwit
  • Peter Reiss
  • James H Stein
  • James D Neaton
  • INSIGHT SMART Study Group
There are contradictory reports regarding the effects of protease inhibitors on the ECG measures of QT and PR interval durations. The effect of interrupting use of protease inhibitors on QT and PR progression is also unknown.
Original languageEnglish
JournalAIDS
Volume25
Issue number3
Pages (from-to)367-77
Number of pages11
ISSN0269-9370
DOIs
Publication statusPublished - 28 Jan 2011

    Research areas

  • Adult, Anti-Retroviral Agents, Dose-Response Relationship, Drug, Electrocardiography, Ambulatory, Female, HIV-1, Humans, Long QT Syndrome, Male, Protease Inhibitors, Treatment Outcome, Viral Load

ID: 35413784